Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
Immunopharmacology and Immunotoxicology|November 24, 2015
A case of netherton syndrome: successful treatment with omalizumab and pulse prednisolone and its effects on cytokines and immunoglobulin levelsArzu Didem YalcinMedical Science Monitor : International Medical Journal of Experimental and Clinical Research|September 23, 2014
An overview of the effects of anti-IgE therapiesArzu Didem YalcinLe Infezioni in Medicina|July 2, 2016
Erratum: Circulating Apo 2L levels decreased in genotype II hepatitis C with pegylated interferon-2 alpha treatmentArzu Didem YalcinImmunopharmacology and Immunotoxicology|July 2, 2020
A case of asthma with Behcet's disease: successful treatment with omalizumab and its effects on recurrent aphthous lesionsArzu Didem Yalcin, Ata Nevzat YalcinImmunopharmacology and Immunotoxicology|September 5, 2020
Future perspective: biologic agents in patients with severe COVID-19Arzu Didem Yalcin, Ata Nevzat YalcinPathology Oncology Research : POR|June 6, 2019
Tissue HE4 Expression Discriminates the Ovarian Serous Carcinoma but Not the Uterine Serous Carcinoma Patients. A New Adjunct to the Origin of the Tumor SiteBetul Celik, Tangul Bulut, Arzu Didem YalcinExpert Opinion on Biological Therapy|December 24, 2013
D-dimer levels decreased in severe allergic asthma and chronic urticaria patients with the omalizumab treatmentArzu Didem Yalcin, Betul Celik, Saadet GumusluImmunopharmacology and Immunotoxicology|April 29, 2016
Omalizumab (anti-IgE) therapy in the asthma-COPD overlap syndrome (ACOS) and its effects on circulating cytokine levelsArzu Didem Yalcin, Betul Celik, Ata Nevzat YalcinMedical Science Monitor : International Medical Journal of Experimental and Clinical Research|February 28, 2012
Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: its relation to omalizumab treatmentArzu Didem Yalcin, Atil Bisgin, Aysegul Kargi, et al.Pageof 5